NewGenIvf Group (NIVF) Competitors $0.74 -0.07 (-8.63%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends NIVF vs. MRAI, BRTX, CMAX, OTRK, BGLC, KDLY, VSEE, OPGN, ACON, and BACKShould you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Marpai (MRAI), BioRestorative Therapies (BRTX), CareMax (CMAX), Ontrak (OTRK), BioNexus Gene Lab (BGLC), Kindly MD (KDLY), Vsee Health (VSEE), OpGen (OPGN), Aclarion (ACON), and IMAC (BACK). These companies are all part of the "healthcare" industry. NewGenIvf Group vs. Marpai BioRestorative Therapies CareMax Ontrak BioNexus Gene Lab Kindly MD Vsee Health OpGen Aclarion IMAC Marpai (NASDAQ:MRAI) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership. Which has more risk and volatility, MRAI or NIVF? Marpai has a beta of 4.84, meaning that its share price is 384% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.26, meaning that its share price is 74% less volatile than the S&P 500. Do institutionals & insiders hold more shares of MRAI or NIVF? 49.8% of Marpai shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 61.3% of Marpai shares are held by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is MRAI or NIVF more profitable? NewGenIvf Group has a net margin of 0.00% compared to Marpai's net margin of -92.76%. Company Net Margins Return on Equity Return on Assets Marpai-92.76% N/A -99.32% NewGenIvf Group N/A N/A N/A Does the MarketBeat Community believe in MRAI or NIVF? Marpai received 2 more outperform votes than NewGenIvf Group when rated by MarketBeat users. CompanyUnderperformOutperformMarpaiOutperform Votes266.67% Underperform Votes133.33% NewGenIvf GroupN/AN/A Which has stronger valuation & earnings, MRAI or NIVF? NewGenIvf Group has lower revenue, but higher earnings than Marpai. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarpai$37.15M0.27-$28.75M-$3.32-0.22NewGenIvf Group$5.14M0.54$130KN/AN/A Does the media prefer MRAI or NIVF? In the previous week, NewGenIvf Group had 1 more articles in the media than Marpai. MarketBeat recorded 1 mentions for NewGenIvf Group and 0 mentions for Marpai. NewGenIvf Group's average media sentiment score of 0.02 beat Marpai's score of 0.00 indicating that NewGenIvf Group is being referred to more favorably in the news media. Company Overall Sentiment Marpai Neutral NewGenIvf Group Neutral Do analysts recommend MRAI or NIVF? Marpai presently has a consensus target price of $6.00, indicating a potential upside of 733.33%. Given Marpai's higher possible upside, equities analysts plainly believe Marpai is more favorable than NewGenIvf Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Marpai 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NewGenIvf Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A SummaryNewGenIvf Group beats Marpai on 7 of the 13 factors compared between the two stocks. Ad Crypto 101 MediaMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…All you have to do is claim your free ticket to the event now… Get NewGenIvf Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIVF vs. The Competition Export to ExcelMetricNewGenIvf Grouphealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.75M$1.93B$5.40B$8.53BDividend YieldN/A8.02%5.15%4.14%P/E RatioN/A22.26112.5515.07Price / Sales0.545.431,478.8293.55Price / Cash22.2810.9739.8334.04Price / Book6.744.244.645.01Net Income$130,000.00$69.56M$119.13M$225.46M7 Day Performance-17.68%-3.51%0.78%0.37%1 Month Performance14.00%-11.01%5.65%3.57%1 Year PerformanceN/A-7.80%36.90%29.42% NewGenIvf Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIVFNewGenIvf Group0.7485 of 5 stars$0.74-8.6%N/AN/A$2.75M$5.14M0.00N/ANews CoverageMRAIMarpaiN/A$0.90+11.1%$6.00+566.7%+76.9%$12.37M$37.15M-0.27150BRTXBioRestorative Therapies4.0457 of 5 stars$1.53flat$18.00+1,076.5%-12.2%$10.59M$174,100.00-0.757Short Interest ↓Positive NewsCMAXCareMax3.4828 of 5 stars$2.02+32.0%$45.00+2,127.7%-96.2%$7.68M$784.55M-0.011,450News CoverageGap UpHigh Trading VolumeOTRKOntrak1.9959 of 5 stars$1.78-3.3%$45.00+2,428.1%-88.7%$7.51M$12.39M-0.05250Gap UpBGLCBioNexus Gene Lab0.9921 of 5 stars$0.36-5.2%N/A+3.9%$6.49M$9.18M0.0030Positive NewsKDLYKindly MDN/A$1.03+3.0%N/AN/A$6.13M$3.10M0.00N/ANews CoverageHigh Trading VolumeVSEEVsee HealthN/A$1.63-0.6%N/AN/A$5.88M$6.38M0.00N/AGap DownOPGNOpGenN/A$1.83+2.8%N/A-72.0%$2.47M$2.67M0.00100Analyst ForecastNews CoverageGap UpACONAclarion2.4157 of 5 stars$0.20flat$1.50+658.0%-96.3%$1.62M$53,947.000.007Short Interest ↑News CoverageGap UpBACKIMACN/A$1.19flatN/A-30.7%$1.37M$16.19M0.00180 Related Companies and Tools Related Companies Marpai Alternatives BioRestorative Therapies Alternatives CareMax Alternatives Ontrak Alternatives BioNexus Gene Lab Alternatives Kindly MD Alternatives Vsee Health Alternatives OpGen Alternatives Aclarion Alternatives IMAC Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NIVF) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewGenIvf Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NewGenIvf Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
